Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of CXCR3 signaling in response to anti-PD-1 therapy.
Han X, Wang Y, Sun J, Tan T, Cai X, Lin P, Tan Y, Zheng B, Wang B, Wang J, Xu L, Yu Z, Xu Q, Wu X, Gu Y. Han X, et al. EBioMedicine. 2019 Oct;48:169-177. doi: 10.1016/j.ebiom.2019.08.067. Epub 2019 Sep 11. EBioMedicine. 2019. PMID: 31521609 Free PMC article.
Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial.
Han X, Tang X, Zhu H, Zhu D, Zhang X, Meng X, Hua Y, Wang Z, Zhang Y, Huang W, Wang L, Yuan S, Zhang P, Gong H, Sun Y, Zhang Y, Liu Z, Dong X, Gai F, Huang Z, Zhu C, Guo J, Wang Z. Han X, et al. J Immunother Cancer. 2022 Dec;10(12):e004952. doi: 10.1136/jitc-2022-004952. J Immunother Cancer. 2022. PMID: 36600554 Free PMC article. Clinical Trial.
Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial.
Han X, Guo J, Li L, Huang Y, Meng X, Wang L, Zhu H, Meng X, Shao Q, Li X, Zhang Y, Wang J, Chen Y, Zhang Y, Chen Y, Zhu C, Wang Z. Han X, et al. Signal Transduct Target Ther. 2024 Sep 16;9(1):241. doi: 10.1038/s41392-024-01957-3. Signal Transduct Target Ther. 2024. PMID: 39278918 Free PMC article. Clinical Trial.
20,917 results
You have reached the last available page of results. Please see the User Guide for more information.